Fibroblast collagen synthesis machinery

The fibroblast collagen synthesis machinery is a coordinated system of enzymes, chaperones, and regulatory proteins responsible for the production and assembly of collagen, the primary structural component of the extracellular matrix (ECM) [NIH: StatPearls]. This process begins with the transcription of procollagen genes (such as COL1A1 and COL1A2) and continues through extensive post-translational modifications in the endoplasmic reticulum, including hydroxylation by prolyl 4-hydroxylase (P4H) and lysyl hydroxylase (LH), and glycosylation [PubMed: 16029671]. A critical component of this machinery is the chaperone HSP47 (SERPINH1), which ensures the correct folding and stability of the collagen triple helix before its secretion into the extracellular space [UniProt: P50454]. Once secreted, procollagen is enzymatically cleaved by N- and C-proteinases and cross-linked by lysyl oxidase (LOX) to form mature, stable fibrils [PubMed: 28811263]. Dysregulation of this machinery is a central driver of fibrotic diseases, such as idiopathic pulmonary fibrosis (IPF), liver cirrhosis, and systemic sclerosis, where overactive fibroblasts deposit excessive collagen, leading to organ scarring and failure [PubMed: 26398883]. Therapeutic interventions target various stages of this machinery, including the use of TGF-beta inhibitors like fresolimumab to reduce gene expression, and LOX inhibitors like PXS-5505 to block tissue stiffening [PubMed: 25213234, ClinicalTrials.gov: NCT04676529].

Other names

Collagen biosynthetic pathwayProcollagen processing machineryFibroblast collagen production system

Inhibition of collagen gene expression, post-translational modification enzymes (e.g., prolyl hydroxylase, lysyl oxidase), and molecular chaperones (e.g., HSP47) involved in triple-helix assembly and secretion.